All News

One vaccine dosing regimen for AZD1222 showed 90% efficacy, according to investigators at the University of Oxford.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here's the roundup of this week's coronavirus-related news.

Results from the NIAID-sponsored ACTT-2 trial showed that COVID-19 patients treated with baricitinib in combination with remdesivir experienced better recovery times and clinical status.

Pfizer and BioNTech expect to produce up to 50 million doses globally in 2020 and up to 1.3 billion doses by the end of 2021.

The Department of Health and Human Services recently released a final rule requiring health insurers to disclose drug pricing and cost-sharing information

Pfizer and BioNTech today announced that their COVID-19 vaccine candidate showed a 95% efficacy rate in the final analysis of its phase 3 study.

Community non-profits receive funding to support health equity, healthcare providers, and rural communities.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

As part of a new partnership with HHS, the nation’s largest pharmacy chains—as well as independents and regional chains—will be administering free coronavirus disease 2019 (COVID-19) vaccines when they are available.

AmerisourceBergen has reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC) to include Good Neighbor Pharmacy and Elevate Provider Network members in the Federal Pharmacy Partnership Strategy for COVID-19 Vaccination.

Independent pharmacists should tune in to this webinar event to learn how Good Neighbor Pharmacy's 4 core value centers can help them optimize their business.

Interim analysis results from a phase 3 clinical trial reported a vaccine efficacy rate above 90% for BNT162b2. The trial is ongoing until it meets its threshold for confirmed COVID-19 cases.

Pharmacies are seeing an increased demand for flu vaccines in the first season that coincides with the coronavirus pandemic.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Thinking Long-Term: COVID-19’s Clinical Consequences and Mental Health Effects."

Todd Mizeski, Esq, a Partner in Frier Levitt’s Life Sciences, Litigation Department, discusses the case of Rutledge v. Pharmaceutical Care Management Association.

CMS’ new plan will ensure coverage of COVID-19 vaccines with no out-of-pocket costs, while increasing the number of providers that will administer the vaccine.

Kroger Health is offering rapid antibody testing for coronavirus disease 2019 (COVID-19) across all its pharmacies and clinics by the end of November.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Walmart filed a pre-emptive suit against 2 government agencies that are threatening to sue Walmart over its pharmacists filling opioid prescriptions.

Remdesivir (Veklury; Gilead) is the first and only fully FDA-approved treatment for COVID-19.

The new guidance provides clarification on requirements for pharmacy interns and technicians to administer childhood and COVID-vaccines, as well as COVID-19 tests.

CVS Health is hiring more than 10,000 full-time and part-time pharmacy technicians to meet the demand for flu vaccinations and, in the future, coronavirus disease 2019 (COVID-19) vaccinations.

Policymakers have the power to get pharmacy benefit managers under control.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

The agency warns that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby.

Here's the coronavirus-related news from this week that you should know.

The approval, which was based on the PALM randomized controlled trial, is the first FDA-approved treatment for Ebola virus infection.

If anything has demonstrated the need and value of expanded access to community-based care, it’s been the coronavirus disease 2019 pandemic.

A new report from the National Academies of Sciences, Engineering, and Medicine include pharmacists in the priority group for receiving the COVID-19 vaccine when available.